Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.
Saved in:
| Title: | Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma. |
|---|---|
| Authors: | Jayne WP; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA., Freilich ME; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA., Solanki R; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA., Challagundla KB; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 Mar 11; Vol. 34 (1), pp. 201169. Date of Electronic Publication: 2026 Mar 11 (Print Publication: 2026). |
| Publication Type: | News |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2950-3299 |
|---|---|
| DOI: | 10.1016/j.omton.2026.201169 |
